We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NE icon
1301
Noble Corp
NE
$6.86B
– –
-9,262
Closed -$246K
NGD
1302
DELISTED
New Gold Inc
NGD
– –
-44,656
Closed -$221K
NKE icon
1303
Nike
NKE
$61.9B
– –
-3,755
Closed -$267K
NOC icon
1304
Northrop Grumman
NOC
$82.5B
– –
-796
Closed -$398K
NOV icon
1305
NOV
NOV
$7.33B
– –
-11,286
Closed -$140K
NTLA icon
1306
Intellia Therapeutics
NTLA
$1.69B
– –
-14,457
Closed -$136K
NTR icon
1307
Nutrien
NTR
$31.1B
– –
-5,398
Closed -$315K
NVDA icon
1308
PUT
NVIDIA
NVDA
$5.32T
– –
-907
Closed -$246K
NVEE
1309
DELISTED
NV5 Global
NVEE
– –
-37,796
Closed -$873K
NVO
1310
Novo Nordisk
NVO
$208B
– –
-5,802
Closed -$400K
NXPI icon
1311
NXP Semiconductors
NXPI
$59.1B
– –
-6,086
Closed -$1.33M
NYT icon
1312
New York Times
NYT
$10.4B
– –
-4,551
Closed -$255K
OIS icon
1313
Oil States International
OIS
$525M
– –
-19,700
Closed -$106K
OLMA icon
1314
Olema Pharmaceuticals
OLMA
$1.06B
– –
-22,133
Closed -$94.3K
OLO
1315
DELISTED
Olo Inc
OLO
– –
-14,038
Closed -$125K
ONON icon
1316
On Holding
ONON
$12.9B
– –
-33,583
Closed -$1.75M
OPOF
1317
DELISTED
Old Point Financial
OPOF
– –
-5,708
Closed -$224K
ORI icon
1318
Old Republic International
ORI
$10.3B
– –
-6,384
Closed -$245K
PAGS icon
1319
PagSeguro Digital
PAGS
$2.55B
– –
-15,823
Closed -$153K
PARA
1320
DELISTED
Paramount Global Class B
PARA
– –
-29,575
Closed -$382K
PAYO icon
1321
Payoneer
PAYO
$2.41B
– –
-38,150
Closed -$261K
PEGA icon
1322
Pegasystems
PEGA
$5.41B
– –
-4,910
Closed -$266K
PKG icon
1323
Packaging Corp of America
PKG
$22.6B
– –
-2,149
Closed -$405K
PLD icon
1324
Prologis
PLD
$131B
– –
-5,381
Closed -$566K
PRI icon
1325
Primerica
PRI
$9.78B
– –
-899
Closed -$246K
51 52
53
54 55

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.